Literature DB >> 21363976

African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers.

Benjamin Emmanuel1, Esther Kawira, Martin D Ogwang, Henry Wabinga, Josiah Magatti, Francis Nkrumah, Janet Neequaye, Kishor Bhatia, Glen Brubaker, Robert J Biggar, Sam M Mbulaiteye.   

Abstract

African Burkitt lymphoma is an aggressive B-cell, non-Hodgkin lymphoma linked to Plasmodium falciparum malaria. Malaria biomarkers related to onset of African Burkitt lymphoma are unknown. We correlated age-specific patterns of 2,602 cases of African Burkitt lymphoma (60% male, mean ± SD age = 7.1 ± 2.9 years) from Uganda, Ghana, and Tanzania with malaria biomarkers published from these countries. Age-specific patterns of this disease and mean multiplicity of P. falciparum malaria parasites, defined as the average number of distinct genotypes per positive blood sample based on the merozoite surface protein-2 assessed by polymerase chain reaction, were correlated and both peaked between 5 and 9 years. This pattern, which was strong and consistent across regions, contrasted parasite prevalence, which peaked at 2 years and decreased slightly, and geometric mean parasite density, which peaked between 2 and 3 years and decreased sharply. Our findings suggest that concurrent infection with multiple malaria genotypes may be related to onset of African Burkitt lymphoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21363976      PMCID: PMC3042814          DOI: 10.4269/ajtmh.2011.10-0450

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  36 in total

1.  Sickle cell trait, hemoglobin C trait, and Burkitt's lymphoma.

Authors:  F K Nkrumah; I V Perkins
Journal:  Am J Trop Med Hyg       Date:  1976-07       Impact factor: 2.345

2.  Seasonal variation in onset of Burkitt's lymphoma in the West Nile District of Uganda.

Authors:  E H Williams; N E Day; A G Geser
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

3.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.

Authors:  G Henle; W Henle; P Clifford; V Diehl; G W Kafuko; B G Kirya; G Klein; R H Morrow; G M Munube; P Pike; P M Tukei; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

4.  Burkitt's lymphoma and sickle-cell trait in Uganda.

Authors:  M C Pike
Journal:  Br J Prev Soc Med       Date:  1970-02

5.  Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda.

Authors:  G Peyerl-Hoffmann; T Jelinek; A Kilian; G Kabagambe; W G Metzger; F von Sonnenburg
Journal:  Trop Med Int Health       Date:  2001-08       Impact factor: 2.622

6.  Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana.

Authors:  S Owusu-Agyei; T Smith; H-P Beck; L Amenga-Etego; I Felger
Journal:  Trop Med Int Health       Date:  2002-05       Impact factor: 2.622

7.  Haemoglobin genotypes, ABO blood groups, and Burkitt's tumour.

Authors:  A O Williams
Journal:  J Med Genet       Date:  1966-09       Impact factor: 6.318

Review 8.  The selection landscape of malaria parasites.

Authors:  M J Mackinnon; K Marsh
Journal:  Science       Date:  2010-05-14       Impact factor: 47.728

9.  Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season.

Authors:  A Ofosu-Okyere; M J Mackinnon; M P Sowa; K A Koram; F Nkrumah; Y D Osei; W G Hill; M D Wilson; D E Arnot
Journal:  Parasitology       Date:  2001-08       Impact factor: 3.234

10.  Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997.

Authors:  H R Wabinga; D M Parkin; F Wabwire-Mangen; S Nambooze
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  16 in total

1.  Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009.

Authors:  Peter Aka; Esther Kawira; Nestory Masalu; Benjamin Emmanuel; Glen Brubaker; Josiah Magatti; Sam M Mbulaiteye
Journal:  Pediatr Blood Cancer       Date:  2012-05-22       Impact factor: 3.167

2.  Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.

Authors:  Juan Ravell; Isaac Otim; Hadijah Nabalende; Ismail D Legason; Steven J Reynolds; Martin D Ogwang; Christopher M Ndugwa; Vickie Marshall; Denise Whitby; James J Goedert; Eric A Engels; Kishor Bhatia; Michael J Lenardo; Sam M Mbulaiteye
Journal:  Cancer Epidemiol       Date:  2017-12-14       Impact factor: 2.984

3.  A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls?

Authors:  Sonya Baik; Mike Mbaziira; Makeda Williams; Martin D Ogwang; Tobias Kinyera; Benjamin Emmanuel; John L Ziegler; Steven J Reynolds; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2012-03-13       Impact factor: 2.965

Review 4.  Non-Hodgkin lymphoma, diagnostic, and prognostic particularities in children - a series of case reports and a review of the literature (CARE compliant).

Authors:  Cristina Oana Mărginean; Lorena Elena Meliţ; Emoke Horvath; Horea Gozar; Mihaela Ioana Chinceşan
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

5.  A Cross-Sectional Population Study of Geographic, Age-Specific, and Household Risk Factors for Asymptomatic Plasmodium falciparum Malaria Infection in Western Kenya.

Authors:  Sally Peprah; Constance Tenge; Isaiah O Genga; Mediatrix Mumia; Pamela A Were; Robert T Kuremu; Walter N Wekesa; Peter O Sumba; Tobias Kinyera; Isaac Otim; Ismail D Legason; Joshua Biddle; Steven J Reynolds; Ambrose O Talisuna; Robert J Biggar; Kishor Bhatia; James J Goedert; Ruth M Pfeiffer; Sam M Mbulaiteye
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

6.  Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study.

Authors:  Sally Peprah; Martin D Ogwang; Patrick Kerchan; Steven J Reynolds; Constance N Tenge; Pamela A Were; Robert T Kuremu; Walter N Wekesa; Nestory Masalu; Esther Kawira; Isaac Otim; Ismail D Legason; Leona W Ayers; Kishor Bhatia; James J Goedert; Ruth M Pfeiffer; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2021-06-07       Impact factor: 2.965

7.  Paediatric head and neck cancers in Nigeria: Implications for treatment planning in resource limited settings.

Authors:  Adisa O Akinyele; Agaku T Israel; E E U Akang
Journal:  Niger Med J       Date:  2012-10

8.  Burkitt lymphoma risk in U.S. solid organ transplant recipients.

Authors:  Sam M Mbulaiteye; Christina A Clarke; Lindsay M Morton; Todd M Gibson; Karen Pawlish; Dennis D Weisenburger; Charles F Lynch; Marc T Goodman; Eric A Engels
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 13.265

9.  Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi.

Authors:  W Thomas Johnston; Nora Mutalima; David Sun; Benjamin Emmanuel; Kishor Bhatia; Peter Aka; Xiaolin Wu; E Borgstein; G N Liomba; Steve Kamiza; Nyengo Mkandawire; Mkume Batumba; Lucy M Carpenter; Harold Jaffe; Elizabeth M Molyneux; James J Goedert; Daniel Soppet; Robert Newton; Sam M Mbulaiteye
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

10.  Burkitt lymphoma: epidemiological features and survival in a South African centre.

Authors:  Daniela C Stefan; Rabeen Lutchman
Journal:  Infect Agent Cancer       Date:  2014-06-10       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.